BIGBEAR
PHARMACEUTICAL
Brigatinib is a targeted therapy drug whose main component is a tyrosine kinase inhibitor.
AuthenticGuaranteeFast DeliveryPrivacy As a second-generation ALK tyrosine kinase inhibitor, brigatinib manufactured by Lao Big Bear Pharmaceutical specifically inhibits the activity of ALK···【More】
Update: 16 Jun,2026Source: BigbearViews: 126
As one of the national standard pharmaceutical enterprises in Laos, Big Bear Pharmaceutical has launched a generic version of Brigatinib, manufactured···【More】
Update: 16 Jun,2026Source: BigbearViews: 128
The generic version of Brigatinib launched by BigbearPharma in Laos is an oral targeted therapy for the treatment of anaplastic lymphoma kinase (ALK)-···【More】
Update: 16 Jun,2026Source: BigbearViews: 129
Brigatinib (Alunbrig), also known as brigatinib, is a targeted therapy with the active ingredient brigatinib, commonly formulated as film-coated table···【More】
Update: 03 Mar,2026Source: BigbearViews: 134
Brigatinib (Alunbrig), also known as brigatinib, is a targeted therapy for anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCL···【More】
Update: 03 Mar,2026Source: BigbearViews: 139
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
